Diabetology Limited is an award winning clinical stage biopharmaceutical company employing a proprietary oral delivery system to administer known drugs as well as novel compounds to transform the treatment outcomes for patients with diabetes.
Our oral delivery technology can be applied to a broad range of APIs and we can enter into strategic partnerships and collaborative product development arrangements
Diabetology has received several accolades for its superior growth strategy, important technology innovation and effective leverage of core competencies